CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade AngioDynamics, Inc. - ANGO CFD

    6.23
    2.13%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.05
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    AngioDynamics Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 6.1
    Open* 6.06
    1-Year Change* -30.42%
    Day's Range* 6.04 - 6.24
    52 wk Range 5.72-13.69
    Average Volume (10 days) 922.27K
    Average Volume (3 months) 11.93M
    Market Cap 232.75M
    P/E Ratio -100.00K
    Shares Outstanding 39.86M
    Revenue 329.54M
    EPS -0.36
    Dividend (Yield %) N/A
    Beta 0.72
    Next Earnings Date Mar 28, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 19, 2024 6.23 0.26 4.36% 5.97 6.24 5.96
    Apr 18, 2024 6.10 -0.14 -2.24% 6.24 6.35 6.08
    Apr 17, 2024 6.30 -0.14 -2.17% 6.44 6.48 6.27
    Apr 16, 2024 6.46 0.28 4.53% 6.18 6.53 6.17
    Apr 15, 2024 6.29 0.03 0.48% 6.26 6.39 6.21
    Apr 12, 2024 6.35 -0.34 -5.08% 6.69 6.79 6.29
    Apr 11, 2024 6.78 0.03 0.44% 6.75 6.99 6.71
    Apr 10, 2024 6.82 0.10 1.49% 6.72 7.02 6.69
    Apr 9, 2024 6.94 0.07 1.02% 6.87 7.14 6.80
    Apr 8, 2024 6.59 -0.50 -7.05% 7.09 7.11 6.57
    Apr 5, 2024 6.99 0.19 2.79% 6.80 7.44 6.75
    Apr 4, 2024 6.36 0.06 0.95% 6.30 7.14 6.19
    Apr 3, 2024 6.06 0.02 0.33% 6.04 6.33 6.02
    Apr 2, 2024 6.18 0.36 6.19% 5.82 6.27 5.82
    Apr 1, 2024 5.80 -0.01 -0.17% 5.81 6.01 5.72
    Mar 28, 2024 5.84 0.17 3.00% 5.67 5.87 5.66
    Mar 27, 2024 5.68 0.34 6.37% 5.34 5.68 5.34
    Mar 26, 2024 5.38 0.14 2.67% 5.24 5.45 5.22
    Mar 25, 2024 5.25 -0.02 -0.38% 5.27 5.45 5.22
    Mar 22, 2024 5.33 -0.11 -2.02% 5.44 5.53 5.31

    AngioDynamics, Inc. Events

    Time (UTC) Country Event
    Wednesday, July 10, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q4 2024 AngioDynamics Inc Earnings Release
    Q4 2024 AngioDynamics Inc Earnings Release

    Forecast

    -

    Previous

    -
    Wednesday, October 2, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q1 2025 AngioDynamics Inc Earnings Release
    Q1 2025 AngioDynamics Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total revenue 338.752 316.219 291.01 264.157 270.634
    Revenue 338.752 316.219 291.01 264.157 270.634
    Cost of Revenue, Total 164.506 150.487 134.222 113.885 114.634
    Gross Profit 174.246 165.732 156.788 150.272 156
    Total Operating Expense 389.933 344.69 326.293 431.255 280.03
    Selling/General/Admin. Expenses, Total 144.252 133.752 117.224 116.506 111.731
    Research & Development 29.883 30.739 36.39 29.682 28.258
    Depreciation / Amortization 18.79 19.458 18.136 18.121 17.056
    Unusual Expense (Income) 30.182 9.042 20.232 164.592 15.127
    Other Operating Expenses, Total 2.32 1.212 0.089 -11.531 -6.776
    Operating Income -51.181 -28.471 -35.283 -167.098 -9.396
    Interest Income (Expense), Net Non-Operating -2.702 -0.688 -0.861 -0.907 -5.099
    Other, Net -0.554 -0.79 0.092 -0.13 -0.207
    Net Income Before Taxes -54.437 -29.949 -36.052 -168.135 -14.702
    Net Income After Taxes -52.442 -26.547 -31.548 -166.787 -11.146
    Net Income Before Extra. Items -52.442 -26.547 -31.548 -166.787 -11.146
    Total Extraordinary Items 0 0 72.486
    Net Income -52.442 -26.547 -31.548 -166.787 61.34
    Income Available to Common Excl. Extra. Items -52.442 -26.547 -31.548 -166.787 -11.146
    Income Available to Common Incl. Extra. Items -52.442 -26.547 -31.548 -166.787 61.34
    Diluted Net Income -52.442 -26.547 -31.548 -166.787 61.34
    Diluted Weighted Average Shares 39.48 39.009 38.342 37.961 37.485
    Diluted EPS Excluding Extraordinary Items -1.32832 -0.68054 -0.82281 -4.39364 -0.29735
    Diluted Normalized EPS -0.8314 -0.52987 -0.47982 -1.57536 -0.03504
    Aug 2023 May 2023 Feb 2023 Nov 2022 Aug 2022
    Total revenue 78.679 91.074 80.712 85.429 81.537
    Revenue 78.679 91.074 80.712 85.429 81.537
    Cost of Revenue, Total 38.619 44.715 40.208 40.351 39.232
    Gross Profit 40.06 46.359 40.504 45.078 42.305
    Total Operating Expense 43.649 111.911 89.64 93.544 94.838
    Selling/General/Admin. Expenses, Total 38.224 36.521 34.245 36.842 36.644
    Research & Development 7.941 7.86 6.852 6.838 8.333
    Depreciation / Amortization 3.625 4.406 4.739 4.808 4.837
    Unusual Expense (Income) -44.63 18.173 3.369 3.059 5.581
    Other Operating Expenses, Total -0.13 0.236 0.227 1.646 0.211
    Operating Income 35.03 -20.837 -8.928 -8.115 -13.301
    Interest Income (Expense), Net Non-Operating 0.119 -0.901 -0.736 -0.684 -0.381
    Other, Net -0.288 -0.127 0 -0.252 -0.175
    Net Income Before Taxes 34.861 -21.865 -9.664 -9.051 -13.857
    Net Income After Taxes 45.884 -21.467 -9.485 -8.486 -13.004
    Net Income Before Extra. Items 45.884 -21.467 -9.485 -8.486 -13.004
    Net Income 45.884 -21.467 -9.485 -8.486 -13.004
    Income Available to Common Excl. Extra. Items 45.884 -21.467 -9.485 -8.486 -13.004
    Income Available to Common Incl. Extra. Items 45.884 -21.467 -9.485 -8.486 -13.004
    Diluted Net Income 45.884 -21.467 -9.485 -8.486 -13.004
    Diluted Weighted Average Shares 39.968 39.612 39.509 39.49 39.302
    Diluted EPS Excluding Extraordinary Items 1.14802 -0.54193 -0.24007 -0.21489 -0.33087
    Diluted Normalized EPS 0.4222 -0.24373 -0.18465 -0.16454 -0.23857
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total Current Assets 163.542 143.345 140.879 152.913 315.292
    Cash and Short Term Investments 45.514 30.931 50.956 54.435 227.641
    Cash & Equivalents 44.62 28.825 48.161 54.435 227.641
    Short Term Investments 0.894 2.106 2.795 0
    Total Receivables, Net 52.826 52.304 35.407 34.174 43.577
    Accounts Receivable - Trade, Net 52.826 52.304 35.405 31.263 43.577
    Total Inventory 55.325 51.392 48.614 59.905 40.071
    Prepaid Expenses 3.723 4.524 3.991 4.399 4.003
    Other Current Assets, Total 6.154 4.194 1.911 0
    Total Assets 532.637 552.751 561.438 594.214 836.438
    Property/Plant/Equipment, Total - Net 49.497 51.979 46.455 38.458 24.258
    Property/Plant/Equipment, Total - Gross 108.523 103.048 92.09 79.119 65.866
    Accumulated Depreciation, Total -59.026 -51.069 -45.635 -40.661 -41.608
    Goodwill, Net 159.238 201.058 201.316 200.515 347.666
    Intangibles, Net 111.144 152.38 168.977 197.136 145.387
    Other Long Term Assets, Total 49.216 3.989 3.811 5.192 3.835
    Total Current Liabilities 83.825 74.324 57.584 51.445 73.302
    Accounts Payable 40.445 28.047 19.63 19.096 22.829
    Accrued Expenses 28.539 37.402 37.874 31.457 38.338
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 7.5
    Other Current Liabilities, Total 14.841 8.875 0.08 0.892 4.635
    Total Liabilities 154.341 128.262 121.981 139.342 221.623
    Total Long Term Debt 49.818 25 20 40 124.407
    Long Term Debt 49.818 25 20 40 124.407
    Deferred Income Tax 12.813 16.037 19.955 24.057 14.542
    Other Liabilities, Total 7.885 12.901 24.442 23.84 9.372
    Total Equity 378.296 424.489 439.457 454.872 614.815
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.382 0.38 0.377 0.374 0.372
    Additional Paid-In Capital 599.206 586.879 573.507 561.871 555.04
    Retained Earnings (Accumulated Deficit) -210.855 -158.413 -131.866 -100.318 66.469
    Treasury Stock - Common -5.714 -5.714 -5.714 -5.714 -5.714
    Other Equity, Total -4.723 1.357 3.153 -1.341 -1.352
    Total Liabilities & Shareholders’ Equity 532.637 552.751 561.438 594.214 836.438
    Total Common Shares Outstanding 39.6114 39.1712 38.5509 38.0785 37.6144
    Unrealized Gain (Loss) 0 0
    Aug 2023 May 2023 Feb 2023 Nov 2022 Aug 2022
    Total Current Assets 175.475 163.542 152.574 158.83 151.371
    Cash and Short Term Investments 57.586 44.62 30.111 29.857 24.564
    Cash & Equivalents 57.586 44.62 30.111 29.857 24.564
    Total Receivables, Net 49.755 52.826 50.892 52.852 53.586
    Accounts Receivable - Trade, Net 49.755 52.826 50.892 52.852 53.586
    Total Inventory 59.972 55.325 63.532 63.177 57.609
    Prepaid Expenses 8.162 4.617 8.039 12.944 15.612
    Total Assets 493.949 532.637 542.849 558.207 557.652
    Property/Plant/Equipment, Total - Net 47.94 49.497 50.702 51.705 52.524
    Goodwill, Net 159.017 159.238 199.976 200.755 201.038
    Intangibles, Net 106.671 111.144 134.011 141.943 147.976
    Other Long Term Assets, Total 4.846 49.216 5.586 4.974 4.743
    Total Current Liabilities 57.452 83.825 69.632 73.567 66.39
    Accounts Payable 24.807 40.445 35.6 34.688 29.258
    Accrued Expenses 27.837 28.539 24.074 29.024 28.146
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Other Current Liabilities, Total 4.808 14.841 9.958 9.855 8.986
    Total Liabilities 66.145 154.341 145.194 150.249 143.611
    Total Long Term Debt 0 49.818 49.807 49.796 49.798
    Long Term Debt 0 49.818 49.807 49.796 49.798
    Deferred Income Tax 1.279 12.813 13.49 14.29 15.115
    Other Liabilities, Total 7.414 7.885 12.265 12.596 12.308
    Total Equity 427.804 378.296 397.655 407.958 414.041
    Redeemable Preferred Stock 0 0 0 0 0
    Common Stock 0.383 0.382 0.382 0.381 0.381
    Additional Paid-In Capital 603.759 599.206 596.225 593.482 589.984
    Retained Earnings (Accumulated Deficit) -164.971 -210.855 -189.388 -179.903 -171.417
    Treasury Stock - Common -5.714 -5.714 -5.714 -5.714 -5.714
    Other Equity, Total -5.653 -4.723 -3.85 -0.288 0.807
    Total Liabilities & Shareholders’ Equity 493.949 532.637 542.849 558.207 557.652
    Total Common Shares Outstanding 40.2166 39.6114 39.6064 39.5041 39.4777
    Other Current Assets, Total 0 6.154
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -26.547 -31.548 -166.787 61.34 16.335
    Cash From Operating Activities -7.194 24.093 -14.554 37.44 41.287
    Cash From Operating Activities 29.349 25.916 23.805 25.88 23.163
    Deferred Taxes -3.708 -4.805 -1.568 -2.655 -8.947
    Non-Cash Items 14.759 25.458 158.545 -45.861 8.276
    Cash Taxes Paid 0.329 0.313 0.682 0.426 0.036
    Cash Interest Paid 0.562 0.731 0.413 5.115 3.19
    Changes in Working Capital -21.047 9.072 -28.549 -1.264 2.46
    Cash From Investing Activities -19.307 -13.711 -63.345 82.554 -3.656
    Capital Expenditures -4.297 -5.187 -7.585 -3.118 -3.656
    Other Investing Cash Flow Items, Total -15.01 -8.524 -55.76 85.672 0
    Cash From Financing Activities 7.683 -16.986 -95.242 33.931 -11.551
    Financing Cash Flow Items 0 0 -1.983 -8.1 -9.5
    Issuance (Retirement) of Stock, Net 2.683 3.014 -0.759 2.031 2.949
    Issuance (Retirement) of Debt, Net 5 -20 -92.5 40 -5
    Foreign Exchange Effects -0.518 0.33 -0.065 -0.38 0.472
    Net Change in Cash -19.336 -6.274 -173.206 153.545 26.552
    Feb 2023 Nov 2022 Aug 2022 May 2022 Feb 2022
    Net income/Starting Line -30.975 -21.49 -13.004 -26.547 -20.281
    Cash From Operating Activities -15.876 -17.246 -24.745 -7.194 -15.754
    Cash From Operating Activities 23.316 15.478 7.66 29.349 21.682
    Deferred Taxes -1.752 -1.525 -0.907 -3.708 -3.121
    Non-Cash Items 12.531 9.915 3.892 14.759 10.768
    Changes in Working Capital -18.996 -19.624 -22.386 -21.047 -24.802
    Cash From Investing Activities -8.218 -6.072 -3.576 -19.307 -15.534
    Capital Expenditures -3.296 -2.63 -1.349 -4.297 -3.258
    Other Investing Cash Flow Items, Total -4.922 -3.442 -2.227 -15.01 -12.276
    Cash From Financing Activities 25.42 24.479 24.376 7.683 7.354
    Financing Cash Flow Items -0.751 -0.751 -0.706 0
    Issuance (Retirement) of Stock, Net 1.171 0.23 0.082 2.683 2.354
    Issuance (Retirement) of Debt, Net 25 25 25 5 5
    Foreign Exchange Effects -0.04 -0.129 -0.316 -0.518 -0.337
    Net Change in Cash 1.286 1.032 -4.261 -19.336 -24.271

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    AngioDynamics, Inc. Company profile

    About AngioDynamics, Inc.

    AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

    Financial summary

    BRIEF: For the six months ended 30 November 2021, AngioDynamics, Inc. revenues increased 9% to $155.3M. Net loss increased 80% to $15.3M. Revenues reflect United States segment increase of 13% to $129.8M. Higher net loss reflects Sales and marketing - Balancing value increase of 27% to $48M (expense), Legal increase from $2M to $4.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.22 to -$0.39.

    Equity composition

    Common Stock $.01 Par, 08/11, 45M auth., 24,975,757 issd. Insiders & Strategic Owns 1.71%. IPO5/27/04,1.95M shares @ $11 by RBC Capital Markets. 01/07, Co. acquired RITA Medical Systems, Inc. @ 0.1722 shares (23,340,205 shares issd.).

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    14 Plaza Dr
    LATHAM
    NEW YORK 12110
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    A way forward: a roundup of recent central bank decisions

    Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

    12:47, 22 March 2024

    Bank of Japan Preview: will the BOJ end negative interest rates?

    The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

    08:44, 18 March 2024

    People also watch

    US100

    17,037.80 Price
    -1.980% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 7.0

    XRP/USD

    0.53 Price
    +4.000% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    Gold

    2,392.09 Price
    +0.540% 1D Chg, %
    Long position overnight fee -0.0192%
    Short position overnight fee 0.0110%
    Overnight fee time 21:00 (UTC)
    Spread 0.40

    ETH/USD

    3,046.91 Price
    -1.150% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading